Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

Progress Reports: Dartmouth College: Arsenic as an Endocrine Disrupter

Superfund Research Program

Arsenic as an Endocrine Disrupter

Project Leaders: Joshua W. Hamilton (Marine Biological Laboratory), Joshua W. Hamilton (Marine Biological Laboratory)
Grant Number: P42ES007373
Funding Period: 1995-2014

Learn More About the Grantee

Visit the grantee's eNewsletter page Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Facebook page Visit the grantee's Video page

Progress Reports

Year:   2013  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995 

This project is examining the mechanisms by which exposure to arsenic and chromium contribute to human disease risk. Dr. Hamilton has previously shown that arsenic can act as an endocrine disruptor, blocking the ability of glucocorticoid hormone to signal through its hormone receptor. It has now been demonstrated that similar effects of arsenic on signaling by the estrogen, testosterone and mineralocorticoid receptors in both cell culture and whole animal models. These steroid hormone receptors are all part of the nuclear receptor superfamily, and arsenic may also disrupt other members of this critical family of regulatory proteins, which may be a major contributor to effects of arsenic on vascular disease, diabetes and many different arsenic-associated cancers. Project investigators have also demonstrated a new pathway for chromium signaling in the cell, in which chromium(III), the essential trace element form of chromium, stimulates the cyclic AMP (cAMP) signaling pathway, which in turn contributes to many different cellular responses.

to Top